3
Announcements
Trials
Browse
Landscape
Status
Unknown
4
Completed
4
Withdrawn
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Mouth Neoplasms
1
Mouth Diseases
1
Lichen Planus, Oral
1
Leukoplakia, Oral
1
Keratosis, Actinic
1
Graft vs Host Disease
1
Actinic cheilitis
1
Interventions
pembrolizumab
65
Nivolumab
58
Ipilimumab
32
Cyclophosphamide
22
Specimen Handling
16
Magnetic Resonance Spectroscopy
15
Biopsy
15
relatlimab
13
cemiplimab
13
fludarabine
12
Opdualag
12
binimetinib
10
Blood Specimen Collection
10
aldesleukin
9
Radiosurgery
9
encorafenib
8
Interleukin-2
8
atezolizumab
7
Immunotherapy
7
tebentafusp
6
mogamulizumab
6
fludarabine phosphate
6
Temozolomide
6
Surgical Procedures, Operative
6
Paclitaxel
6
Immunoglobulin G
6
CTLA-4 Antigen
6
Radiotherapy
5
Disulfides
5
Bevacizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Tomography, Optical Coherence
×
Dermatologic
×
Clear all
NCT06321003
2025-05-23
SYMILIS OCT
University of Palermo
Recruiting
200 enrolled